The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries: Results of the Sub-Saharan Africa Survey of Heart FailureDAMASCENO, Albertino; MAYOSI, Bongani M; YONGA, Gerald et al.Archives of internal medicine (1960). 2012, Vol 172, Num 18, pp 1386-1394, issn 0003-9926, 9 p.Article

Design of the RELAXin in Acute Heart Failure StudyPONIKOWSKI, Piotr; METRA, Marco; MUELLER-VELTEN, Guenther et al.The American heart journal. 2012, Vol 163, Num 2, pp 149-155, issn 0002-8703, 7 p.Article

The Safety of an Adenosine A₁-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment: Findings from PROTECTTEERLINK, John R; IRAGUI, Vicente J; ZILE, Michael R et al.Drug safety. 2012, Vol 35, Num 3, pp 233-244, issn 0114-5916, 12 p.Article

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With OutcomesMETRA, Marco; COTTER, Gad; DOROBANTU, Maria I et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 2, pp 196-206, issn 0735-1097, 11 p.Article

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialTEERLINK, John R; COTTER, Gad; DOROBANTU, Maria I et al.Lancet (British edition). 2013, Vol 381, Num 9860, pp 29-39, issn 0140-6736, 11 p.Article

The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart FailureVAN DER MEER, Peter; POSTMUS, Douwe; TEERLINK, John R et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 19, pp 1973-1981, issn 0735-1097, 9 p.Article

Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMETRA, Marco; O'CONNOR, Christopher M; JIA, Gang et al.European heart journal. 2011, Vol 32, Num 12, pp 1519-1534, issn 0195-668X, 16 p.Article